Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AdaptHealth (AHCO) EBITDA Margin (2019 - 2026)

AdaptHealth has reported EBITDA Margin over the past 7 years, most recently at 2.27% for Q4 2025.

  • For Q4 2025, EBITDA Margin fell 1905.0% year-over-year to 2.27%; the TTM value through Dec 2025 reached 13.94%, down 467.0%, while the annual FY2025 figure was 13.94%, 466.0% down from the prior year.
  • EBITDA Margin for Q4 2025 was 2.27% at AdaptHealth, down from 18.81% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 21.32% in Q4 2024 and troughed at 46.11% in Q3 2023.
  • A 5-year average of 11.95% and a median of 17.53% in 2022 define the central range for EBITDA Margin.
  • Biggest five-year swings in EBITDA Margin: crashed -6400bps in 2023 and later skyrocketed 6456bps in 2024.
  • Year by year, EBITDA Margin stood at 19.1% in 2021, then fell by -20bps to 15.25% in 2022, then crashed by -200bps to 15.26% in 2023, then skyrocketed by 240bps to 21.32% in 2024, then plummeted by -89bps to 2.27% in 2025.
  • Business Quant data shows EBITDA Margin for AHCO at 2.27% in Q4 2025, 18.81% in Q3 2025, and 20.8% in Q2 2025.